207_Combined course Presentations
Efficacy of Chemo-Radiotherapy in Stage III Non-Small Cell Lung Cancer and PD-L1 expression J Adam, A. Boros, B. Lacas, L. Lacroix, J.-P. Pignon, C. Caramella, D. Planchard, A. Levy, B. Besse, C. Le Pechoux
Progression free survival (PFS)
Overall survival (OS)
PD-L1 -
PD-L1 -
Median OS: 2 years
Median PFS: 1 year
PD-L1 +
Median OS: 1.1 years
Median PFS: 0.7 year
PD-L1 +
Made with FlippingBook